CRE8 Sirolimus-Eluting Stent

sirolimus-eluting stent · CID S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRE8 Sirolimus-Eluting Stent, covering 2015-03-25 to 2015-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions